The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7492-7500

  Halloran, Margaret M ^a   Woods, James M ^a   Strieter, Robert M ^b   Szekanecz, Zoltan ^a   Volin, Michael V ^a   Hosaka, Shigeru ^a   Haines III, G Kenneth ^a,c   Kunkel, Steven L ^b   Burdick, Marie D ^b   Walz, Alfred ^d   Koch, Alisa E ^a,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c Depts of Medicine and Pathology   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

^e Department of Rheumatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CHEMOTAXIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78;

ANGIOGENESIS; ANIMAL CELL; ARTHRITIS; ARTICLE; DRUG EFFECT; DRUG INDUCED DISEASE; ENDOTHELIUM CELL; LEUKOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; SYNOVIAL FLUID; TISSUE HOMOGENATE;

EID: 0033564324     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Harris, E. D. 1988. Pathogenesis of rheumatoid arthritis: a disorder associated with dysfunctional immunoregulation. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 751.
2. Harris, E. D. 1990. Rheumatoid arthritis: pathophysiology and implications for therapy. N. Engl. J. Med. 332:1277.
3. Szekanecz, Z., G. Szegedi, and A. E. Koch. 1996. Cellular adhesion molecules in rheumatoid arthritis: regulation by cytokines and possible clinical importance. J. Invest. Med. 44:124.
4. Lipsky, P. E., L. S. Davis, J. J. Cush, and N. Oppenheimer-Marks. 1989. The role of cytokines in the pathogenesis of rheumatoid arthritis. Springer Semin. Immunopathol. 11:123.
5. Arend, W. P., and J. M. Dayer. 1990. Cytokines and cytokine inhibitors in rheumatoid arthritis. Arthritis Rheum. 33:305.
6. Miller, M. D., and M. S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17.
7. Baggiolini, M., B. Dewald, and B. Moser. 1993. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:97.
8. Oppenheim, J. J., C. O. C. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene intercrine cytokine family. Annu. Rev. Immunol. 9:617.
9. 3C motif. Nature 385:640.
10. Strieter, R. M., S. L. Kunkel, A. Shanafelt, D. A. Arenberg, A. E. Koch, and P. J. Polverini. 1996. Role of C-X-C chemokines in regulation of angiogenesis. In Chemokines in Disease. A. E. Koch and R. M. Strieter, eds. R. G. Landes, Austin, p. 195.
11. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, and D. Marriott. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:27348.
12. Verani, A., G. Scarlatti, M. Comar, E. Tresoldi, S. Polo, M. Giacca, P. Lussa, A. G. Siccardi, and D. Vercelli. 1997. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185:805.
13. Walz, A., R. Burgener, B. Car, M. Baggiolini, S. L. Kunkel, and R. M. Strieter. 1991. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J. Exp. Med. 174:1355.
14. Koch, A. E., S. L. Kunkel, L. A. Harlow, D. D. Mazarakis, G. K. Haines, M. D. Burdick, R. M. Pope, A. Walz, and R. M. Strieter. 1994. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J. Clin. Invest. 94:1012.
15. Wooley, P. H. 1991. Animal models of rheumatoid arthritis. Curr. Opin. Rheumatol. 3:407.
16. Taurog, J. D., D. C. Argentieri, and R. A. McReynolds. 1988. Adjuvant arthritis. Methods Enzymol. 162:339.
17. Van de Loo, F. A., L. A. B. Joosten, P. L. E. M. Van Lent, O. J. Arntz, and W. B. Van den Berg. 1995. Role of interleukin-1, tumor necrosis factor-α, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Arthritis Rheum. 38:164.
18. Issekutz, A. C., A. Meager, and I. Otterness. 1994. The role of tumor necrosis factor-α and IL-1 in polymorphonuclear leukocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin. Exp. Immunol. 97:26.
19. Sugita, T., O. Furukawa, M. Ueno, T. Murakami, I. Takata, and T. Tosa. 1993. Enhanced expression of interleukin-6 in rat and murine arthritis models. J. Immunopharmacol. 15:469.
20. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
21. Endo, H., T. Akahoshi, K. Takagishi, S. Kashiwazaki, and K. Matsushima. 1991. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res. 10:245.
22. Halloran, M. M., Z. Szekanecz, N. Barquin, G. K. Haines, and A. E. Koch. 1996. Cellular adhesion molecules in rat adjuvant arthritis. Arthritis Rheum. 39:810.
23. Langman, C. B., K. K. Ford, L. M. Pachman, and F. Glorieux. 1990. Vitamin D metabolism in rats with adjuvant-induced arthritis. J. Bone Miner. Res. 5:905.
24. 486IL-2) in rat adjuvant arthritis. Eur. J. Immunol. 22:1673.
25. Strieter, R. M., S. L. Kunkel, M. D. Burdick, P. M. Lincoln, and A. Walz. 1992. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol. Invest. 21:589.
26. Winer, B. J. 1971. Statistical Principles in Experimental Design. McGraw Hill, New York.
27. Parsons, P. E., A. A. Fowler, T. M. Hyers, and P. M. Henson. 1985. Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132:490.
28. Hayes, A. A., A. H. Rose, A. W. Musk, and B. W. Robinson. 1988. Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals. Chest 94:521.
29. Colletti, L. M., S. L. Kunkel, A. Walz, M. D. Burdick, R. G. Kunkel, C. A. Wilke, and R. M. Strieter. 1995. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. J. Clin. Invest. 95:134.
30. Williams, A. S., J. P. Camilleri, N. Amos, and B. D. Williams. 1995. Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis. Clin. Exp. Immunol. 102:560.
31. Bradbeer, J. N., R. D. Kapadia, S. K. Sarkar, H. Zhao, G. B. Stroup, B. A. Swift, D. J. Rieman, and A. M. Badger. 1996. Disease-modifying activity of SK&F 106615 in rat adjuvant-arthritis: multiparameter analysis of disease magnetic resonance imaging and bone mineral density measurements. Arthritis Rheum. 39: 504.
32. Thorbecke, G. J., R. Shah, and C. H. Leu. 1992. Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA 89:7375.
33. Kasama, T., R. M. Strieter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95: 2868.
34. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:27348.
35. Marinova-Mutafchieva, L., R. O. Williams, L. J. Manson, C. Mauri, M. Feldmann, and R. N. Maini. 1997. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol. 107:507.
36. Joosten, L. A. B., M. M. A. Helen, F. A. J. van de Loo, and W. B. Van de Berg. 1996. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNF-α, anti-IL-1α/β, and IL-1Ra. Arthritis Rheum. 39:797.
37. Arvilommi, A. M., M. Salmi, and S. Jalkanen. 1997. Organ-selective regulation of vascular adhesion protein-1 expression in man. Eur. J. Immunol. 27:1794.
38. Jalkanen, S., R. A. Reichert, W. M. Gallatin, R. F. Bargatze, I. L. Weissman, and E. C. Butcher. 1986. Homing receptors and the control of lymphocyte migration. Immunol. Rev. 91:39.
39. Butcher, E. C., D. Lewinsohn, A. Duijvestijn, R. Bargatze, N. Wu, and S. Jalkanen. 1986. Interactions between endothelial cells and leukocytes. J. Cell. Biochem. 30:121.